Patient safety is Boston Scientific’s highest priority and our constant focus in helping care for people living with complex, debilitating and often life-threatening conditions. We provide innovative medical solutions that improve the health of more than 25 million patients around the world each year.

The outcomes experienced by the majority of patients were not reflected in recent reporting, and without sufficient context this could discourage individuals from seeking the care they need from a physician. While we can’t completely eliminate risk when complex technologies and patient conditions are involved, we aim to have the lowest possible rate of adverse events associated with our products, and never stop working to further improve the safety and effectiveness of our devices.

We have a strong safety record, with an average annual complaint rate across our entire product range of less than 0.15%, and an even lower rate of adverse events.

Safety monitoring is a constant process that begins with product design and development, is built into clinical trials and continues after our products are approved for use. We monitor and review multiple sources of information to track product safety, including post-market surveillance studies, patient registry information, quality systems feedback and real-world evidence.